ArticleCurrent urology2024

Treatment of intermediate-risk prostate cancer with active surveillance in the routine care-Long-term outcomes of a prospective noninterventional study (HAROW).

Lothar Weissbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.